Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Uttarakhand Tribal Villages Ban Liquor, Beer, Chowmein, Momos, Tikki, Chaat & Other Fast Foods At Weddings; ₹1 Lakh Fine Announced
Navi Mumbai: Heavy Vehicles Banned During Peak Hours On Mandwa Jetty–Alibag Road To Curb Accidents; Check Timings
Rana Daggubati Launches His Tequila Brand Loca Loka In Mumbai: Shares A Memory With Actor Nagarjuna
'Borders May Change': Defence Minister Rajnath Singh Says Sindh May Return To India Again At Sindhi Samaj Sammelan - VIDEO
(With inputs from PTI)
